Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...

Favre revealed his diagnosis with Parkinson's disease. Now, he's working to find treatment solutions. Favre joined Ambio Life ...

Discover how Parkinson's disease begins in the gut, not the brain. Learn the early digestive warning signs that appear years ...

A team of researchers at UCLA has developed a high-tech diagnostic pen that can detect signs of Parkinson’s disease with over ...

Los Angeles Times readers give their thoughts on Bill Plaschke's poignant column on Parkinson's disease, the Dodgers and the ...

Ventyx Biosciences has shared phase 2a data on a Parkinson’s disease prospect that has caught the eye of Sanofi. The readout shows the effect of VTX3232 on biomarkers, providing some of the data that ...

SBS’sGood Boy is riding high after hitting a new all-time ratings high of 6.2% nationwide in episode 6—but it’s not just the ...

Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug candidate as a treatment for other neurodegenerative diseases, including ...

A new study suggests long-term exposure to chemicals used to keep fairways green may be tied to an increased risk of ...

MJFF co-founder and CEO Deborah W. Brooks read a letter of gratitude from Michael J. Fox for the support of the mission from ...

Basel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational ...

May 27, 2025 — Persons with Parkinson's disease increasingly lose their mobility over time and are eventually unable to walk. Hope for these patients rests on deep brain stimulation, also known ...